Cysteinylated Albumin as a Potential Biomarker for the Progression of Kidney Disease in Patients With Type 2 Diabetes.
Imafuku T, Watanabe H, Oniki K, Yoshida A, Kato H, Nakano T, Tokumaru K, Fujita I, Arimura N, Maeda H, Sakamoto Y, Kondo N, Morita A, Saruwatari J, Tanaka M, Matsushita K, Wada T, Fukagawa M, Otagiri M, Fitzgerald ML, Jinnouchi H, Maruyama T.
Imafuku T, et al. Among authors: nakano t.
Diabetes Care. 2021 Jun;44(6):e115-e117. doi: 10.2337/dc20-3003. Epub 2021 Apr 26.
Diabetes Care. 2021.
PMID: 33905348
Free PMC article.
No abstract available.